Replies to post #6917 on Biotech Values

[DewDiligence]

>>…most of your concerns listed here are true for all biotech companies and drugs.<<

True, but it’s a matter of degree. When you are talking about long-term treatment with a systemic drug for a small organ like the eye, the concern is greater.